(Q37824829)

23 August 2017

1 reference

title

Serum biomarkers for improved diagnostic of pancreatic cancer: a current overview (English)

1 reference

23 August 2017

0 references

0 references

1 reference

S Bünger

1

1 reference

23 August 2017

T Laubert

series ordinal

2

1 reference

23 August 2017

U J Roblick

series ordinal

3

1 reference

23 August 2017

J K Habermann

series ordinal

4

1 reference

23 August 2017

publication date

31 December 2010

1 reference

Journal of Cancer Research and Clinical Oncology

23 August 2017

published in

1 reference

23 August 2017

volume

137

1 reference

23 August 2017

issue

3

1 reference

23 August 2017

page(s)

375-389

1 reference

https://scigraph.springernature.com/pub.10.1007/s00432-010-0965-x

23 August 2017

exact match

0 references

cites work

Towards complete and accurate reporting of studies of diagnostic accuracy: the STARD initiative. Standards for Reporting of Diagnostic Accuracy

1 reference

https://api.crossref.org/works/10.1007%2FS00432-010-0965-X

Minimum information about a microarray experiment (MIAME)-toward standards for microarray data

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-010-0965-X

Up-to-date cancer survival: period analysis and beyond.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-010-0965-X

Identification of potential markers for the detection of pancreatic cancer through comparative serum protein expression profiling

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-010-0965-X

Serum peptidome profiling revealed platelet factor 4 as a potential discriminating Peptide associated with pancreatic cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-010-0965-X

Improved diagnosis of pancreatic adenocarcinoma using haptoglobin and serum amyloid A in a panel screen.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-010-0965-X

CAM 17.1--a new diagnostic marker in pancreatic cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-010-0965-X

A new approach to managing intraductal papillary mucinous pancreatic neoplasms

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-010-0965-X

Time-dependent evolution of tissue markers by MALDI-MS imaging

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-010-0965-X

Systematic review of carbohydrate antigen (CA 19-9) as a biochemical marker in the diagnosis of pancreatic cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-010-0965-X

CA 242, a new tumour marker for pancreatic cancer: a comparison with CA 19-9, CA 50 and CEA

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-010-0965-X

Serum level of TSGF, CA242 and CA19-9 in pancreatic cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-010-0965-X

Tumor-node-metastasis staging of pancreatic adenocarcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-010-0965-X

Serum macrophage inhibitory cytokine 1 as a marker of pancreatic and other periampullary cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-010-0965-X

Serum heat shock protein 27 is increased in chronic pancreatitis and pancreatic carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-010-0965-X

Diagnostic laparoscopy improves staging of pancreatic cancer deemed locally unresectable by computed tomography

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-010-0965-X

Evolving preoperative evaluation of patients with pancreatic cancer: does laparoscopy have a role in the current era?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-010-0965-X

REporting recommendations for tumour MARKer prognostic studies (REMARK)

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-010-0965-X

Protein profiling of microdissected pancreas carcinoma and identification of HSP27 as a potential serum marker

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-010-0965-X

Metastatic pancreatic cancer 2008: is the glass less empty?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-010-0965-X

A prospective study of serum tumour markers carcinoembryonic antigen, carbohydrate antigens 50 and 242, tissue polypeptide antigen and tissue polypeptide specific antigen in the diagnosis of pancreatic cancer with special reference to multivariate d

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-010-0965-X

Plasma storage at -80 degrees C does not protect matrix metalloproteinase-9 from degradation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-010-0965-X

Banking of biological fluids for studies of disease-associated protein biomarkers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-010-0965-X

CONSORT 2010 Statement: Updated guidelines for reporting parallel group randomised trials.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-010-0965-X

The minimum information about a proteomics experiment (MIAPE)

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-010-0965-X

Measurement error correction using validation data: a review of methods and their applicability in case-control studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-010-0965-X

Tumor M2-pyruvate kinase, a new metabolic marker for pancreatic cancer

21 January 2018

2 references

https://api.crossref.org/works/10.1007%2FS00432-010-0965-X

21 January 2018

12 December 2020

Serum tumor antigen REG4 as a diagnostic biomarker in pancreatic ductal adenocarcinoma

1 reference

https://api.crossref.org/works/10.1007%2FS00432-010-0965-X

[Present status of and prospects for basic research on pancreatic cancer]

21 January 2018

1 reference

12 December 2020

Meta-Analyses of Chemotherapy for Locally Advanced and Metastatic Pancreatic Cancer

1 reference

12 December 2020

Detection of early-stage pancreatic adenocarcinoma

1 reference

12 December 2020

CEACAM1, a novel serum biomarker for pancreatic cancer

1 reference

12 December 2020

Pre-analytical factors in clinical proteomics investigations: impact of ex vivo protein modifications for multiple sclerosis biomarker discovery

1 reference

12 December 2020

Comparison of circulating MMP-9, TIMP-1 and CA19-9 in the detection of pancreatic cancer

1 reference

12 December 2020

Prospective study of CAM 17.1/WGA mucin assay for serological diagnosis of pancreatic cancer

1 reference

12 December 2020

Serum levels of granulocyte colony-stimulating factor (G-CSF) and macrophage colony-stimulating factor (M-CSF) in pancreatic cancer patients

1 reference

12 December 2020

Assessment of the biological variation of plasma tissue inhibitor of metalloproteinases-1.

1 reference

12 December 2020

Detection of serum tumor markers in the diagnosis and treatment of patients with pancreatic cancer

1 reference

12 December 2020

Current and emerging techniques in gastrointestinal imaging

1 reference

12 December 2020

Localization of Pancreatic Endocrine Tumors by Endoscopic Ultrasonography

1 reference

12 December 2020

Cancer antigens 19-9 and 125 in the differential diagnosis of pancreatic mass lesions.

1 reference

12 December 2020

The clinical value of serum CEA, CA19-9, and CA242 in the diagnosis and prognosis of pancreatic cancer

1 reference

12 December 2020

Evaluation of the diagnostic value of serum tumor markers, and fecal k-ras and p53 gene mutations for pancreatic cancer

1 reference

12 December 2020

CEA, CA 19-9, and CA 125 in the differential diagnosis of benign and malignant pancreatic diseases with or without jaundice

1 reference

12 December 2020

Significance of serum receptor-binding cancer antigen (RCAS1) in pancreatic cancer and benign pancreatobiliary diseases

1 reference

12 December 2020

Behavior of tumor markers CA19.9, CA195, CAM43, CA242, and TPS in the diagnosis and follow-up of pancreatic cancer

1 reference

12 December 2020

Combined detection of serum tumor markers for differential diagnosis of solid lesions located at the pancreatic head

1 reference

12 December 2020

Serum markers in patients with resectable pancreatic adenocarcinoma: macrophage inhibitory cytokine 1 versus CA19-9

1 reference

12 December 2020

Pancreatic cancer: diagnosis and endoscopic staging

1 reference

12 December 2020

Clinical Significance of the Measurements of Serum Matrix Metalloproteinase-9 and Its Inhibitor (Tissue Inhibitor of Metalloproteinase-1) in Patients With Pancreatic Cancer

1 reference

12 December 2020

Biology and management of pancreatic cancer

1 reference

12 December 2020

Evaluation of Sample Handling in Relation to Levels of Tissue Inhibitor of Metalloproteinases-1 Measured in Blood by Immunoassay

1 reference

12 December 2020

Adjuvant therapy for pancreatic cancer: one small step forward

1 reference

12 December 2020

Evaluation of osteopontin as biomarker for pancreatic adenocarcinoma.

1 reference

12 December 2020

Prediction of resectability of pancreatic malignancy by computed tomography

1 reference

12 December 2020

10.1007/S00432-010-0965-X

Identifiers

DOI

1 reference

23 August 2017

1 reference